BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36334414)

  • 21. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis.
    Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF
    Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.
    Nayak B; Lal G; Kumar S; Das CJ; Saraya A; Shalimar
    Front Cell Infect Microbiol; 2021; 11():753249. PubMed ID: 34760721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells.
    Kim ES; Jeon MT; Kim KS; Lee S; Kim S; Kim DG
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
    Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
    Elife; 2022 Feb; 11():. PubMed ID: 35191378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer's Disease Patients.
    Chiricosta L; Gugliandolo A; Mazzon E
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Immunohistochemical Reagents for In Situ Protein Expression Analysis of Coronavirus-associated Changes in Human Tissues.
    Szabolcs M; Sauter JL; Frosina D; Geronimo JA; Hernandez E; Selbs E; Rapkiewicz AV; Rekhtman N; Baine MK; Jäger E; Travis WD; Jungbluth AA
    Appl Immunohistochem Mol Morphol; 2021 Jan; 29(1):5-12. PubMed ID: 33086222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Docked severe acute respiratory syndrome coronavirus 2 proteins within the cutaneous and subcutaneous microvasculature and their role in the pathogenesis of severe coronavirus disease 2019.
    Magro CM; Mulvey JJ; Laurence J; Seshan S; Crowson AN; Dannenberg AJ; Salvatore S; Harp J; Nuovo GJ
    Hum Pathol; 2020 Dec; 106():106-116. PubMed ID: 33058948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropathological findings in Down syndrome, Alzheimer's disease and control patients with and without SARS-COV-2: preliminary findings.
    Granholm AE; Englund E; Gilmore A; Head E; Yong WH; Perez SE; Guzman SJ; Hamlett ED; Mufson EJ
    Acta Neuropathol; 2024 May; 147(1):92. PubMed ID: 38801558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Links between COVID-19 and Alzheimer's Disease-What Do We Already Know?
    Rudnicka-Drożak E; Drożak P; Mizerski G; Zaborowski T; Ślusarska B; Nowicki G; Drożak M
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2).
    Lee JH; Choi M; Jung Y; Lee SK; Lee CS; Kim J; Kim J; Kim NH; Kim BT; Kim HG
    Biosens Bioelectron; 2021 Jan; 171():112715. PubMed ID: 33099241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating the Potential Shared Molecular Mechanisms between COVID-19 and Alzheimer's Disease via Transcriptomic Analysis.
    Fan Y; Liu X; Guan F; Hang X; He X; Jin J
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38257800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The COVID-19 pandemic and Alzheimer's disease: mutual risks and mechanisms.
    Chen F; Chen Y; Wang Y; Ke Q; Cui L
    Transl Neurodegener; 2022 Sep; 11(1):40. PubMed ID: 36089575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future.
    Amadoro G; Latina V; Stigliano E; Micera A
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19-related neuropathology and microglial activation in elderly with and without dementia.
    Poloni TE; Medici V; Moretti M; Visonà SD; Cirrincione A; Carlos AF; Davin A; Gagliardi S; Pansarasa O; Cereda C; Tronconi L; Guaita A; Ceroni M
    Brain Pathol; 2021 Sep; 31(5):e12997. PubMed ID: 34145669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The differential immune response in mild versus fatal SARS-CoV2 infection.
    Suster D; Tili E; Nuovo GJ
    Ann Diagn Pathol; 2022 Dec; 61():152032. PubMed ID: 36113259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular cross-talk between long COVID-19 and Alzheimer's disease.
    Pszczołowska M; Walczak K; Misków W; Antosz K; Batko J; Karska J; Leszek J
    Geroscience; 2024 Jun; 46(3):2885-2899. PubMed ID: 38393535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
    Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
    Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses.
    Paidi RK; Jana M; Raha S; McKay M; Sheinin M; Mishra RK; Pahan K
    J Neuroimmune Pharmacol; 2021 Dec; 16(4):743-755. PubMed ID: 34677731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.